OPUS

Opus Group

Market Cap 1,982.9M

Opus was founded in the early 90's in Gothenburg where their head office is still situated. During the first years the strategy was to provide AB Svensk Bilprovning with equipment for emission testing as the catalytic converters were introduced in the market. Step by step Opus extended its offering and costumer base and grew internationally. The big change, from an equipment supplier to a service provider, came in 2008 when Opus aquired Systech, a US based vehicle testing company. Since then revenues from vehicle inspection programs has grown substantially, more than 25 percent annually during 2008-16, excluding the acquisitions of Envirotest and the Swedish operations. These programs make upp for approximately 90 percent of revenues whereas the remaining 10 percent comes from equipment sales. Starting in 2018 Opus will report two divisions: Vehicle Inspection and Intelligent Vehicle Suport. The latter is a newly formed division assisting vehicle technicians with model-specific vehicle systems data.  Opus currently operates a number of vehicle inspection programs in North and South America, Sweden and Pakistan. Sweden is an open market, but in reality it is an oligopoly since the barriers of entry are rather high. In the other markets the authorities give exclusive rights to run testing programs, usually for a period of 8-10 years. In both cases revenues are stable and EBITDA-margins around 20 percent. The company has around 2 000 employees at their facilites in North- and South America, Sweden, UK and Pakistan. The shares are listed on Nasdaq Stockholms Main market. 

+ more

Redeye Research

Reports

Notes

Today
Day High
6.85
6.83
Day Low
6.78
Day Open
6.80
Prev Close
6.83
VWAP
6.8
Volume
241K
Turnover
1.640M
Top Broker
VWAP
6.8
Avg Volume
268K
Avg Turnover
1.820M
Top Brokers
NON/AVA
VWAP
6.8
Avg Volume
228K
Avg Turnover
1.553M
Top Brokers
AVA/NON
VWAP
6.7
Avg Volume
229K
Avg Turnover
1.543M
Top Brokers
AVA/XTX
52 week summary
Price Range
5.5
Last
7.7
Beta
N/A
Market Cap
1,982.9M
Total Return
-2.4%
Trailing P/E
24.4
Div Yield
0.7%
Shares Outstanding
290.3M
Next Earnings Date
15 Nov
Stock Exchange
NASDAQ Stockholm
5 day chart Go to advanced chart

Identify and measure trend strength in stocks with our Momentum tool to identify potential entry and exit signals. The tool provides a set of the most simple but powerful indicators that identify whether a stock is under sell or buy pressure.

Relative Price Strength
Change 3 Months -11.6%
Change 12 Months -6.7%
Volume Trend
Average Volume 10 vs 60 Days -10.4%
Price VS
52 Week High -11.8%
50 Day Moving Average 3.6%
200 Day moving Average 3.7%

Add article markers

Compare Opus Group to

Prev Close 0 Change 0
High 0 Avg Daily Volume 0
Low 0 Avg Daily Turnover 0
Last updated: 2018-01-29 Source: Redeye
Major Owners Equity Votes
RWC Fonder 15.2%
15.2%
Magnus Greko 14.6%
14.6%
Lothar Geilen 6.8%
6.8%
Andra AP-fonden 6.4%
6.4%
Avanza Pension 5.6%
5.6%
Dimensional Fund Advisors 2.8%
2.8%
Schroders 1.3%
1.3%
Nordnet Pensionsförsäkring 1.2%
1.2%
Per Hamberg 1.0%
1.0%
Carl Erik Norman 0.8%
0.8%
Last updated: 2018-05-17 Source: Redeye/Holdings
Timeframe Transactions Net Shares
Last 12 weeks
1 Purchases
20,000
0 Sales
0
Last 24 weeks
1 Purchases
20,000
0 Sales
0
Report Date Name Position Transaction Shares Chg Est Value (SEK)

Insider trades are behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Source: Millistream
  •  
  • Profitability
  • ROE
  • ROCE
  • ROIC
  • EBITDA margin
  • EBIT margin
  • Net margin
  • Per share data (SEK)
  • EPS
  • EPS adj
  • Dividend
  • Net debt
  • Total shares
  • Valuation
  • EV (SEKm)
  • P/E
  • P/E diluted
  • P/Sales
  • EV/Sales
  • EV/EBITDA
  • EV/EBIT
  • P/BV
  • Capital structure
  • Equity ratio
  • Debt/equity ratio
  • Net debt(SEKm)
  • Capital employed(SEKm)
  • Capital turnover rate
  • (SEKm)
  • Net sales
  • Total operating costs
  • EBITDA
  • Depreciation
  • Amortization
  • Impairment charges
  • EBIT
  • Share in profits
  • Net financial items
  • Exchange rate dif.
  • Pre-tax profit
  • Tax
  • Net earnings
  • (SEKm)
  • Assets
  • Current assets
  • Cash in banks
  • Receivables
  • Inventories
  • Other current assets
  • Current assets
  • Fixed assets
  • Tangible assets
  • Associated comp.
  • Investments
  • Goodwill
  • Cap. exp. for dev.
  • O intangible rights
  • O non-current assets
  • Total fixed assets
  • Deferred tax assets
  • Total (assets)
  • Liabilities
  • Current liabilities
  • Short-term debt
  • Accounts payable
  • O current liabilities
  • Current liabilities
  • Long-term debt
  • O long-term liabilities
  • Convertibles
  • Total Liabilities
  • Deferred tax liab
  • Provisions
  • Shareholders' equity
  • Minority interest (BS)
  • Minority & equity
  • Total liab & SE
  • (SEKm)
  • Net sales
  • Total operating costs
  • Depreciations total
  • EBIT
  • Taxes on EBIT
  • NOPLAT
  • Depreciation
  • Gross cash flow
  • Change in WC
  • Gross CAPEX
  • Free cash flow
  • 2015
  •  
  • 8.7%
  • 6.4%
  • 6.8%
  • 16.6%
  • 6.6%
  • 4.0%
  •  
  • 0.23
  • 0.23
  • 0.10
  •  
  • 288.7
  •  
  • 2,436.0
  • 26.2
  • 26.9
  • 1.0
  • 1.5
  • 8.9
  • 22.4
  • 1.9
  •  
  • 33.9%
  • 35.7%
  • 704
  • 1,595
  • 0.6
  • 2015
  •  
  •  
  • 256
  • 97
  • 81
  • 165
  • 599
  •  
  • 739
  • 0
  • 14
  • 791
  • 427
  • 33
  • 0
  • 2,003
  • 29
  • 2,631
  •  
  •  
  • 264
  • 39
  • 392
  • 695
  • 696
  • 0
  • 0
  • 1,391
  • 234
  • 115
  • 891
  • 0
  • 891
  • 2,631
  • 2015
  • 1,652
  • -1,377
  • -166
  • 109
  • -19
  • 90
  • 166
  • 256
  • 16
  • -561
  • 14
  • 2015 Q2
  • 0
  • 40
  • 40
  • -40
  • -17
  • 0
  • 0
  • 0
  • -54
  • 0
  • -54
  • -3
  • -57
  • 2015 Q3
  • 0
  • 40
  • 40
  • -40
  • -17
  • 0
  • 0
  • 0
  • 1
  • 0
  • 1
  • -9
  • -8
  • 2015 Q4
  • 1,652
  • -1,495
  • 156
  • -48
  • -24
  • 0
  • 109
  • 0
  • -16
  • 0
  • 93
  • 9
  • 101
  • 2016
  •  
  • 8.9%
  • 7.5%
  • 5.5%
  • 19.6%
  • 8.8%
  • 5.0%
  •  
  • 0.30
  • 0.30
  • 0.12
  •  
  • 288.7
  •  
  • 2,583.9
  • 22.0
  • 22.6
  • 1.1
  • 1.5
  • 7.8
  • 17.3
  • 1.8
  •  
  • 34.7%
  • 38.9%
  • 685
  • 1,727
  • 0.6
  • 2016
  •  
  •  
  • 507
  • 100
  • 85
  • 224
  • 917
  •  
  • 815
  • 0
  • 23
  • 791
  • 381
  • 49
  • 0
  • 2,058
  • 32
  • 3,007
  •  
  •  
  • 204
  • 42
  • 350
  • 597
  • 988
  • 0
  • 0
  • 1,585
  • 280
  • 100
  • 1,029
  • 13
  • 1,042
  • 3,007
  • 2016
  • 1,698
  • -1,366
  • -183
  • 149
  • -62
  • 87
  • 183
  • 271
  • -105
  • -239
  • -44
  • 2016 Q1
  • 0
  • 44
  • 44
  • -44
  • -18
  • 0
  • 0
  • 0
  • -21
  • 0
  • -21
  • 5
  • -16
  • 2016 Q2
  • 0
  • 44
  • 44
  • -44
  • -18
  • 0
  • 0
  • 0
  • 4
  • 0
  • 4
  • -27
  • -23
  • 2016 Q3
  • 0
  • 45
  • 45
  • -45
  • -18
  • 0
  • 0
  • 0
  • -6
  • 0
  • -6
  • -23
  • -30
  • 2016 Q4
  • 1,698
  • -1,498
  • 199
  • -50
  • -21
  • 0
  • 149
  • 0
  • 19
  • 0
  • 168
  • -15
  • 153
  • 2017
  •  
  • 8.3%
  • 2.9%
  • 4.3%
  • 16.6%
  • 5.7%
  • 4.4%
  •  
  • 0.28
  • 0.28
  • 0.05
  •  
  • 290.3
  •  
  • 2,866.6
  • 23.2
  • 23.9
  • 1.0
  • 1.5
  • 9.3
  • 26.9
  • 2.0
  •  
  • 28.4%
  • 46.0%
  • 966
  • 1,912
  • 0.6
  • 2017
  •  
  •  
  • 643
  • 100
  • 133
  • 111
  • 986
  •  
  • 831
  • 0
  • 25
  • 963
  • 440
  • 53
  • 0
  • 2,312
  • 32
  • 3,331
  •  
  •  
  • 497
  • 201
  • 300
  • 998
  • 1,112
  • 0
  • 0
  • 2,110
  • 200
  • 74
  • 940
  • 7
  • 947
  • 3,331
  • 2017
  • 1,860
  • -1,552
  • -201
  • 107
  • -33
  • 74
  • 201
  • 275
  • 175
  • -455
  • -40
  • 2017 Q1
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 2
  • 3
  • 2017 Q2
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 10
  • 11
  • 2017 Q3
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 0
  • 9
  • 12
  • 2017 Q4
  • 1,860
  • -1,552
  • 308
  • -201
  • -81
  • 0
  • 107
  • 0
  • -104
  • 0
  • 3
  • 49
  • 55
  • 2018 E
  • 2018 E
  • 2018 E
  • 2018 E
  • 2019 E
  • 2019 E
  • 2019 E
  • 2019 E
  • 2020 E
  • 2020 E
  • 2020 E
  • 2020 E

Estimated Values are behind membership

To access members-only content, you must login or register an account.

Our membership is about gaining access to unique research and knowledge through our analysts and a network of peers. Be the first to get information about news and research in the Nordic life science and technology sectors and use our tools and education to reach your personal and professional goals in investing.

Last updated: 2018-05-17 Source: Redeye
Source: Redeye

Presentations, research interviews and videos from our events listed here.

Source: Redeye

When selecting comparable companies, we try to group companies that are in the same or similar sector or subsector. But, more important, have growth, margins and risk characteristics similar to the company being valued.